After in vitro induction with rosiglitazone and bone morphogenetic protein-2 (BMP-2), post-EMT breast cancer cells were transformed into adipocytes expressing various adipocyte markers and responding to isoproterenol and insulin in the same manner as adipocytes. The gene discussed is BMP2; the disease is breast cancer.